LutzS, BalboniT, JonesJ, et al.: Palliative radiotherapy for bone metastases: Update of an ASTRO evidence-based guideline. Pract Radiat Oncol, 2016;pII:S1879–S8500.
2.
LimPS, HoskinPJ: Bone metastases. In: JohnstoneC, LutzST (eds): Handbook of Palliative Radiation Therapy. New York: DemosMedical, 2017.
3.
DeutschM, TersakJM: Radiotherapy for symptomatic metastases to bone in children. Am J Clin Oncol, 2004; 27:128–131.
4.
ChowE, ZengL, SalvoN, et al.: Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol, 2012; 24:112–124.
5.
ChowE, MeyerRM, DingK, et al.: Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: A double-blind, randomized placebo-controlled, phase 3 trial. Lancet Oncol, 2015; 16:1463–1472.
6.
IshiwataT, IwasawaS, KurimotoR, et al.: Comment on: Prophylactic dexamethasone for radiation-induced bone-pain flare. Lancet Oncol, 2016; 17:e39–e40.
7.
Van der LindenYM, SteenlandE, van HouwelingenHC, et al.: Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: Results on survival in the Dutch Bone Metastasis Study. Radiother Oncol, 2006; 78:245–253.
8.
ChowE, van der LindenYM, RoosD, et al.: Single versus multiple fractions of repeat radiation for painful bone metastases: A randomized, controlled, non-inferiority trial. Lancet Oncol, 2014; 15:164–171.
9.
KonskiA, JamesJ, HartsellW, et al.: Economic analysis of radiation therapy oncology group 97-14: Multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol, 2009; 32:423–428.
10.
KonskiA: Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Radiat Oncol Biol Phys, 2004; 60:1373–1378.
11.
Van den HoutWB, van der LindenYM, SteenlandE, et al.: Single-versus multiple-fraction radiotherapy in patients with painful bone metastases: Cost-utility analysis based on a randomized trial. J Natl Cancer Inst, 2003; 95:222–229.
12.
PollicinoCA, TurnerSL, RoosDE, O'BrienPC: Costing the components of pain management: Analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): One versus five fractions for neuropathic bone pain. Radiother Oncol, 2005; 76:264–269.
13.
RutterCE, YuJB, WilsonLD, ParkHS: Assessment of national practice for palliative radiation therapy for bone metastases suggests marked underutilization of single-fraction regimens in the United States. Int J Radiat Oncol Biol Phys, 2015; 91:548–555.
14.
FischbergD, BullJ, CasarettD, et al.: Five things physicians and patients should question in hospice and palliative medicine. J Pain Symptom Manage, 2013; 45:595–605.
15.
AshworthA, KongW, ChowE, MackillopWJ: Fractionation of palliative radiation therapy for bone metastases in Ontario: Do practice guidelines guide practice?. Int J Radiat Oncol Biol Phys, 2016; 94:31–39.
16.
OlsonRA, TiwanaM, BarnesM, et al.: Impact of using audit data to improve the evidence-based use of single-fraction radiation therapy for bone metastases in British Columbia.?. Int J Radiat Oncol Biol Phys, 2016; 94:40–47.
